Skip to main content

Advertisement

SpringerLink
Log in

Comorbidities of antiphospholipid syndrome and systemic lupus erythematosus in children

  • Pediatric Rheumatology (S Ozen, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) are autoimmune diseases that can affect multiple organ systems. Increased awareness and new treatment strategies ultimately improved the survival of patients, and disease-related comorbidities became more important. The purpose of this review is to focus on comorbidities in these diseases that had a negative influence on the course of the disease.

Recent findings

There are limited numbers of studies regarding to comorbidities associated with these diseases during childhood. Infections were found to be the most common comorbidity as a result of immunosuppressive agents and dysregulations of the immune system. Other common comorbidities after infections are cardiovascular and cerebrovascular diseases as important causes of mortality and morbidity. In addition, the risk of malignancies, ophthalmologic manifestations, neurologic and renal diseases, musculoskeletal diseases such as vitamin D deficiency, low bone mineral density, and the risk of avascular necrosis were increased in both patient groups.

Summary

For clinicians, it is important to be aware of the comorbidities that may develop during follow-up of APS and SLE patients. Further studies will shed more light on the comorbidities of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thrombosis Haemostasis. 2006;4(2):295–306.

    Article  CAS  Google Scholar 

  2. Alarcón Segovia D, Delezé M, Oria CV, Sánchez Guerrero J, Gómez Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine. 1989;68(6):353–65.

    Article  PubMed  Google Scholar 

  3. Cervera R, Asherson R, Acevedo M, Gomez-Puerta J, Espinosa G, De La Red G, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Diseases. 2004;63(10):1312–7.

    Article  CAS  Google Scholar 

  4. Dlott JS, Roubey RA. Drug-induced lupus anticoagulants and antiphospholipid antibodies. Curr Rheumatol Rep. 2012;14(1):71–8.

    Article  CAS  PubMed  Google Scholar 

  5. Gattorno M, Falcini F, Ravelli A, Zulian F, Buoncompagni A, Martini G, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus. 2003;12(6):449–53.

    Article  CAS  PubMed  Google Scholar 

  6. Avčin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007;16(8):627–33.

    Article  PubMed  Google Scholar 

  7. Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nature Rev Rheumatol. 2010;6(9):538.

    Article  CAS  Google Scholar 

  8. Wang L-C, Yang Y-H, Lu M-Y, Chiang B-L. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol immunol Infect. 2003;36(3):203–8.

    PubMed  Google Scholar 

  9. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Care Res. 2003;49(4):501–7.

    Article  Google Scholar 

  10. Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, et al. Patient -reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes. 2014;12(1):116.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Moss K, Ioannou Y, Sultan S, Haq I, Isenberg D. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Diseases. 2002;61(5):409–13.

    Article  CAS  Google Scholar 

  12. Chan P-C, Yu C-H, Yeh K-W, Horng J-T, Huang J-L. Comorbidities of pediatric systemic lupus erythematosus: A 6-year nationwide population-based study. J Microbiol Immunol Infect. 2016;49(2):257–63.

    Article  PubMed  Google Scholar 

  13. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15(5):528–34.

    Article  CAS  PubMed  Google Scholar 

  14. Font J, Cervera R, Espinosa G, Pallarés L, Ramos Casals M, Jiménez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Diseases. 1998;57(8):456–9.

    Article  CAS  Google Scholar 

  15. Tucker L, Menon S, Schaller J, Isenberg D. Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology. 1995;34(9):866–72.

    Article  CAS  Google Scholar 

  16. Lee T, von Scheven E, Sandborg C. Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol. 2001;13(5):415–21.

    Article  CAS  PubMed  Google Scholar 

  17. Cervera R, Khamashta M, Hughes G. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus. 2009;18(10):869–74.

    Article  CAS  PubMed  Google Scholar 

  18. Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L. Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology. 2007;46(8):1290–6.

    Article  CAS  PubMed  Google Scholar 

  19. Bosch X, Guilabert A, Pallares L, Cervera R, Ramos-Casals M, Bové A, et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus. 2006;15(9):584–9.

    Article  CAS  PubMed  Google Scholar 

  20. Costa-Reis P, Nativ S, Isgro J, Rodrigues T, Yildirim-Toruner C, Starr A, et al. Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus. Clin Immunol. 2013;149(3):442–9.

    Article  CAS  PubMed  Google Scholar 

  21. Hiraki LT, Feldman CH, Marty FM, Winkelmayer WC, Guan H, Costenbader KH. Serious infection rates among children with systemic lupus erythematosus enrolled in Medicaid. Arthritis Care Res. 2017;69(11):1620–6.

    Article  Google Scholar 

  22. Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek J-H, et al. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Diseases. 2009;41(4):268–74.

    Article  Google Scholar 

  23. Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide M-V, Aguirre C. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Therapy. 2009;11(4):R109.

    Article  CAS  Google Scholar 

  24. Goldblatt F, Chambers S, Rahman A, Isenberg D. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18(8):682–9.

    Article  CAS  PubMed  Google Scholar 

  25. Abramson S, Kramer SB, Radin A, Holzman R. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum. 1985;28(1):75–9.

    Article  CAS  PubMed  Google Scholar 

  26. Shahram F, Akbarian M, Davatchi F. Salmonella infection in systemic lupus erythematosus. Lupus. 1993;2(1):55–9.

    Article  CAS  PubMed  Google Scholar 

  27. Lim E, Koh W, Loh S, Lam M, Howe H. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus. 2001;10(2):87–92.

    Article  CAS  PubMed  Google Scholar 

  28. Chen D, Li H, Xie J, Zhan Z, Liang L, Yang X. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Therapeut Med. 2017;14(6):6222–8.

    CAS  Google Scholar 

  29. Cervera R, Serrano R, Pons-Estel G, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Diseases. 2015;74(6):1011–8.

    Article  CAS  Google Scholar 

  30. Taraborelli M, Reggia R, Dall’Ara F, Fredi M, Andreoli L, Gerosa M, et al. Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study. J Rheumatol. 2017;44(8):1165–72 This study has a multicenter design and provides long-term follow-up results of 115 APS patients.

    Article  PubMed  Google Scholar 

  31. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331–7.

    Article  CAS  PubMed  Google Scholar 

  32. Doria A, Shoenfeld Y, Wu R, Gambari P, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Diseases. 2003;62(11):1071–7.

    Article  CAS  Google Scholar 

  33. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, et al. Understanding premature atherosclerosis in pediatric SLE: risk factors of increased Carotid Intima Medial Thickness (CIMT) in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) cohort. Arthritis Rheum. 2009;60(5):1496.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Roman MJ, Shanker B-A, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. New Engl J Med. 2003;349(25):2399–406.

    Article  CAS  PubMed  Google Scholar 

  35. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Internal Med. 2004;141(10):764–70.

    Article  Google Scholar 

  36. Rees F, Doherty M, Grainge M, Lanyon P, Davenport G, Zhang W. Burden of comorbidity in systemic lupus erythematosus in the UK, 1999–2012. Arthritis Care Res. 2016;68(6):819–27 This study describes accompanying comorbidities in a large patient cohort of UK 7,732 SLE patients.

    Article  Google Scholar 

  37. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):338–46.

    Article  CAS  PubMed  Google Scholar 

  38. Bengtsson C, Öhman M-L, Nived O, Dahlqvist SR. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study. Lupus. 2012;21(4):452–9.

    Article  CAS  PubMed  Google Scholar 

  39. Mok C, Ho L, To C. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol. 2009;38(5):362–8.

    Article  CAS  PubMed  Google Scholar 

  40. Espinosa G, Cervera R. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nature Rev Rheumatol. 2010;6(5):296.

    Article  CAS  Google Scholar 

  41. Medina G, Casaos D, Jara L, Vera-Lastra O, Fuentes M, Barile L, et al. Increased carotid artery intima- media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Diseases. 2003;62(7):607–10.

    Article  CAS  Google Scholar 

  42. Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, et al. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009;28(6):655.

    Article  PubMed  Google Scholar 

  43. George J, Harats D, Gilburd B, Afek A, Shaish A, Kopolovic J, et al. Adoptive transfer of β2- glycoprotein i–reactive lymphocytes enhances early atherosclerosis in LDL receptor–deficient mice. Circulation. 2000;102(15):1822–7.

    Article  CAS  PubMed  Google Scholar 

  44. Bernatsky S, Clarke AE, Niaki OZ, Labrecque J, Schanberg LE, Silverman ED, et al. Malignancy in pediatric-onset systemic lupus erythematosus. J Rheumatol. 2017;44(10):1484–6.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin J-F, Petri M, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130–5.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Mok CC, Ho LY, Fong LS, To CH. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study. Ann Rheum Diseases. 2013;72(5):659–64.

    Article  CAS  Google Scholar 

  47. Merino R. García -Miguel P, García -Consuegra J. Lymphoproliferative disorders in paediatric rheumatic diseases. A report of two cases. Clin Exp Rheumatol. 2004;22(5):649–50.

    CAS  PubMed  Google Scholar 

  48. Gokce M, Bulus D, Bilginer Y, Gumruk F, Besbas N, Cetin M. Acute lymphoblastic leukaemia in a child with systemic lupus erythematosus. Lupus. 2012;21(8):910–3.

    Article  CAS  PubMed  Google Scholar 

  49. Posner M, Gloster E, Bonagura V, Valacer D, Ilowite NT. Burkitt's lymphoma in a patient with systemic lupus erythematosus. J Rheumatol. 1990;17(3):380–2.

    CAS  PubMed  Google Scholar 

  50. Finazzi G. The Italian registry of antiphospholipid antibodies. Haematologica. 1997;82(1):101–5.

    CAS  PubMed  Google Scholar 

  51. Gómez Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos Casals M, et al., editors. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Seminars in arthritis and rheumatism. Amsterdam: Elsevier; 2006.

    Google Scholar 

  52. Lee C, Ramsey-Goldman R. Osteoporosis in systemic lupus erythematosus mechanisms. Rheum Disease Clinics. 2005;31(2):363–85.

    Article  Google Scholar 

  53. Mok CC, Wong SN, Ma KM. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus. Rheumatology. 2011;51(3):468–75.

    Article  PubMed  CAS  Google Scholar 

  54. Lilleby V, Lien G, Frey Frøslie K, Haugen M, Flatø B, Førre Ø. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2005;52(7):2051–9.

    Article  PubMed  Google Scholar 

  55. KSY Y, Northcott M, Hoi AB, Morand EF, Nikpour M. Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med. 2015;2(1):e000064.

    Article  Google Scholar 

  56. Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008;10(4):273.

    Article  CAS  PubMed  Google Scholar 

  57. Amital H, Szekanecz Z, Szücs G, Danko K, Nagy E, Csepany T, et al. Serum concentrations of 25 -OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Diseases. 2010;69(6):1155–7.

    Article  CAS  Google Scholar 

  58. Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni P, Tincani A, et al. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Diseases. 2011;70(1):145–50.

    Article  CAS  Google Scholar 

  59. Piantoni S, Andreoli L, Allegri F, Meroni P, Tincani A. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. Reumatismo. 2012:307–13.

  60. Andreoli L, Piantoni S, Dall’Ara F, Allegri F, Meroni P, Tincani A. Vitamin D and antiphospholipid syndrome. Lupus. 2012;21(7):736–40.

    Article  CAS  PubMed  Google Scholar 

  61. Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB. Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediat Rheumatol. 2015;13(1):13.

    Article  Google Scholar 

  62. Nevskaya T, Gamble MP, Pope JE. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors. Clin Exp Rheumatol. 2017;35(4):700–10.

    PubMed  Google Scholar 

  63. Fraga MM, Len CA, dos Santos Finamor LP, Matos K, Muccioli C, Hilario M, et al. Ocular changes due to the treatment of juvenile systemic lupus erythematosus. Rev Bras Reumatol. 2011;51(6):554–7.

    Article  PubMed  Google Scholar 

  64. Al-Mayouf SM, Al-Hemidan AI. Ocular manifestations of systemic lupus erythematosus in children. Saudi Med J. 2003;24(9):964–6.

    PubMed  Google Scholar 

  65. Asherson R, Merry P, Acheson J, Harris E, Hughes G. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the'primary'antiphospholipid syndrome. Ann Rheum Diseases. 1989;48(5):358–61.

    Article  CAS  Google Scholar 

  66. Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol. 2002;47(3):215–38.

    Article  PubMed  Google Scholar 

  67. Raza H, Epstein SA, Rosenstein DL. Mania: psychiatric manifestations of the antiphospholipid syndrome. Psychosomatics. 2008;49(5):438–41.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Gomez-Puerta J, Cervera R, Calvo L, Gómez Ansón B, Espinosa G, Claver G, et al. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology. 2004;44(1):95–9.

    Article  PubMed  Google Scholar 

  69. Stojanovich L, Kontic M, Smiljanic D, Djokovic A, Stamenkovic B, Marisavljevic D. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Clin Exp Rheumatol. 2013;31(5):756–60.

    PubMed  Google Scholar 

  70. Karabekiroğlu A, Yılmaz A, Kocamanoğlu B. Acute psychotic symptoms: a manifestation of antiphospholipid syndrome or infarction of corpus callosum. Psychiat Danub. 2015;27(3):0-282.

  71. Fukui T. Multiple cognitive impairments associated with systemic lupus erythematosus and antiphospholipid antibody syndrome: A form of progressive vascular dementia? Eur Neurol. 2000;43(2):115.

    Article  CAS  PubMed  Google Scholar 

  72. Huang Y-C, Lyu R-K, Chen S-T, Chu Y-C, Wu Y-R. Parkinsonism in a patient with antiphospholipid syndrome—case report and literature review. J Neurol Sci. 2008;267(1-2):166–9.

    Article  PubMed  Google Scholar 

  73. Carecchio M, Comi C, Varrasi C, Stecco A, Sainaghi PP, Bhatia K, et al. Complex movement disorders in primary antiphospholipid syndrome: a case report. J Neurol Sci. 2009;281(1-2):101–3.

    Article  PubMed  Google Scholar 

  74. Ravelli A, Martini A. Antiphospholipid syndrome. Pediatric Clinics. 2005;52(2):469–91.

    PubMed  Google Scholar 

  75. Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol. 2004;11(1):67–75.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG, et al. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Disease. 2008;30(1):56–64.

    Article  CAS  Google Scholar 

  77. Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015;13(1):43.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Toledano P, Orueta R. Rodríguez -Pintó I, Valls -Solé J, Cervera R, Espinosa G. Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. Autoimmun Rev. 2017;16(7):750–5.

    Article  CAS  PubMed  Google Scholar 

  79. Watad A, Tiosano S, Bragazzi NL, Brigo F, Comaneshter D, Cohen AD, et al. Epilepsy among systemic lupus erythematosus patients: insights from a large database analysis. Neuroepidemiology. 2018;50(1- 2):1–6.

    Article  PubMed  Google Scholar 

  80. Park DJ, Kang JH, Lee KE, Kang SW, Kwok SK, Kim SK, et al. Association of depression with socioeconomic status, anticardiolipin antibodies, and organ damage in patients with systemic lupus erythematosus: results from the KORNET registry. Clin Exp Rheumatol. 2018;36(4):627–35.

    PubMed  Google Scholar 

  81. Amigo M, Garcia-Torres R, Robles M, Bochicchio T, Reyes P. Renal involvement in primary antiphospholipid syndrome. J Rheumatol. 1992;19(8):1181–5.

    CAS  PubMed  Google Scholar 

  82. Sato V, Marques I, Goldenstein P, Carmo L, Jorge L, Titan S, et al. Lupus nephritis is more severe in children and adolescents than in older adults. Lupus. 2012;21(9):978–83.

    Article  CAS  PubMed  Google Scholar 

  83. Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556–62.

    Article  PubMed  Google Scholar 

  84. Al-Mayouf SM, AlAmeer A, Alfattani A, Alsonbul A. Outcome of childhood lupus nephritis in Saudi children. Saudi J Kidney Diseases Transplant. 2017;28(5):1015.

    Article  Google Scholar 

  85. Garcia-Martin F, De Arriba G, Carrascosa T, Moldenhauer F, Martin-Escobar E, Val J, et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dialysis Transplant. 1991;6(8):543–7.

    Article  CAS  Google Scholar 

  86. Sinico RA, Cavazzana I, Nuzzo M, Vianelli M, Napodano P, Scaini P, et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol. 2010;5(7):1211–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.

Author information

Authors and Affiliations

  1. Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Ummusen Kaya Akca

  2. Division of Pediatric Rheumatology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey

    Nuray Aktay Ayaz

Authors
  1. Ummusen Kaya Akca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nuray Aktay Ayaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuray Aktay Ayaz.

Ethics declarations

Disclosure statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Human and Animal rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pediatric Rheumatology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akca, U.K., Ayaz, N.A. Comorbidities of antiphospholipid syndrome and systemic lupus erythematosus in children. Curr Rheumatol Rep 22, 21 (2020). https://doi.org/10.1007/s11926-020-00899-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-020-00899-3

Key words

Search

Navigation